InsiderTrades

Form 4 for VERA Vera Therapeutics, Inc.

Accepted 2024-04-05 00:00:00 ET · period of report 2023-03-14 · accession 0001415889-24-010472 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2024-04-05 2023-03-14 VERA Grant Sean CFO G - Gift $0.00 -14.3K 35.6K -29% $0
MI 2024-04-05 2023-03-14+ VERA Grant Sean CFO G - Gift $0.00 +13.6K 1,620 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-03-14 G D 14,285 $0.00 35,648 D — — (F1) Reflects the number of shares held directly at the time and after giving effect to the reported gift.
2 Common Class A Common Stock 2023-03-14 G A 14,285 $0.00 15,277 I By Trust — — (F2) Reflects the number of shares held by the trust at the time and after giving effect to the reported gift.
3 Common Class A Common Stock 2023-07-24 G D 1,620 $0.00 18,657 I By Trust — — (F3) Reflects the number of shares held by the trust at the time and after giving effect to the reported gift. The number also reflects a purchase reported on a Form 4 filed on June 23, 2023.
4 Common Class A Common Stock 2023-12-20 G D 636 $0.00 18,021 I By Trust — — (F1) Reflects the number of shares held directly at the time and after giving effect to the reported gift.
5 Common Class A Common Stock 2023-07-24 G A 1,620 $0.00 1,620 I As Custodian for UTMA account — — (F4) The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian. (F5) The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.